Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deniz Can

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
Critical Reviews in Oncology/Hematology|January 24, 2026
IMMUNOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: THE CURRENT STATUS AND FUTURE OUTLOOKBahadır Köylü, Fatih Selçukbiricik, Sercan Aksoy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 16, 2022
Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysisOnur Bas, Enes Erul, Deniz Can Guven, et al.
Critical Reviews in Oncology/Hematology|June 17, 2025
IGF-1R inhibitors in cancer: A review of available evidence and future outlookDeniz Can Guven, Jibran Ahmed, Bettzy Stephen, et al.
Turkish Journal of Medical Sciences|April 2, 2020
Data-Driven identification of chemopreventive agents for breast cancerDeniz Can Güven, Cemal Orhan, Kazim Şahin, et al.
Cancers|November 9, 2024
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo, et al.
Expert Review of Anticancer Therapy|March 9, 2026
Harnessing the Power of artificial intelligence for clinical trials in cancerGamze Sonmez, Yigit Yazarkan, Taha Koray Sahin, et al.
Biomarkers in Medicine|October 16, 2020
Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectivesDeniz Can Guven, Taha K Sahin, Omer Dizdar, et al.
Future Oncology (London, England)|February 27, 2020
Gut microbiota and cancer immunotherapy: prognostic and therapeutic implicationsDeniz Can Guven, Burak Yasin Aktas, Cem Simsek, et al.
Tuberkuloz Ve Toraks|April 15, 2021
Thyroid gland metastasis mimicking thyroid carcinoma in a lung cancer patient and dramatic response to crizotinib: A case reportEnes Erul, Deniz Can Güven, Taha Koray Şahin, et al.
Cancers|May 25, 2024
Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Alessandro Rizzo, Sercan Aksoy, et al.
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
Critical Reviews in Oncology/Hematology|January 24, 2026
IMMUNOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: THE CURRENT STATUS AND FUTURE OUTLOOKBahadır Köylü, Fatih Selçukbiricik, Sercan Aksoy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 16, 2022
Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysisOnur Bas, Enes Erul, Deniz Can Guven, et al.
Critical Reviews in Oncology/Hematology|June 17, 2025
IGF-1R inhibitors in cancer: A review of available evidence and future outlookDeniz Can Guven, Jibran Ahmed, Bettzy Stephen, et al.
Turkish Journal of Medical Sciences|April 2, 2020
Data-Driven identification of chemopreventive agents for breast cancerDeniz Can Güven, Cemal Orhan, Kazim Şahin, et al.
Cancers|November 9, 2024
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo, et al.
Expert Review of Anticancer Therapy|March 9, 2026
Harnessing the Power of artificial intelligence for clinical trials in cancerGamze Sonmez, Yigit Yazarkan, Taha Koray Sahin, et al.
Biomarkers in Medicine|October 16, 2020
Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectivesDeniz Can Guven, Taha K Sahin, Omer Dizdar, et al.
Future Oncology (London, England)|February 27, 2020
Gut microbiota and cancer immunotherapy: prognostic and therapeutic implicationsDeniz Can Guven, Burak Yasin Aktas, Cem Simsek, et al.
Tuberkuloz Ve Toraks|April 15, 2021
Thyroid gland metastasis mimicking thyroid carcinoma in a lung cancer patient and dramatic response to crizotinib: A case reportEnes Erul, Deniz Can Güven, Taha Koray Şahin, et al.
Cancers|May 25, 2024
Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Alessandro Rizzo, Sercan Aksoy, et al.
Pageof 20